Carolin Reiser–Erkan

The Activated Stroma Index Is a Novel and Independent Prognostic Marker in Pancreatic Ductal Adenocarcinoma

Mert Erkan, Christoph Michalski, Simon Rieder et al. · Clinical Gastroenterology and Hepatology · 2008 · 414 citations

Tumor Biology, Activated Stroma Index, Pancreatic Cancer +9

StellaTUM: current consensus and discussion on pancreatic stellate cell research

Mert Erkan, Guido Adler, Minoti V. Apte et al. · Gut · 2011 · 414 citations · Full text

Cancer-Stellate Cell Interactions Perpetuate the Hypoxia-Fibrosis Cycle in Pancreatic Ductal Adenocarcinoma

Mert Erkan, Carolin Reiser–Erkan, Christoph Michalski et al. · Neoplasia · 2009 · 284 citations · Full text

Tumor microenvironment and progression of pancreatic cancer.

Mert Erkan, Carolin Reiser–Erkan, C.W. Michalski et al. · PubMed · 2010 · 111 citations

Pathology, Immunotherapeutics, Tumor Mass +16

Comparison of diffusion-weighted MR imaging and multidetector-row CT in the detection of liver metastases in patients operated for pancreatic cancer

Konstantin Holzapfel, Carolin Reiser–Erkan, Alexander A. Fingerle et al. · Abdominal Imaging · 2010 · 104 citations

Engineering, Hepatology, Medical Imaging +12